Concepedia

Author

Peter Verhamme

KU LeuvenORCID

Also Known As

Amalia De Curtis, Christophe Vandenbriele, Jan Vanwelden, Jean-Marie Krzesinski, John D. Varigos, K. Vanhoorelbeke, Kahn, S. R., MM Engelen, Nick van Es, P VERHAMME

749

Publications

35.2K

Citations

75

H-Index

184

Concepts

All Affiliations

KU LeuvenMcMaster UniversityMaastricht UniversityAmsterdam UMC Location University of AmsterdamThrombosis and Atherosclerosis Research Institute
PV

About

Peter Verhamme is an author at KU Leuven specializing in medicine, thrombosis, and cardiovascular disease.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

41

101

10.6K

2

Public Health

26

40

5.6K

3

Health Sciences

15

16

729

4

Engineering

2

2

51

5

Social Sciences

1

1

24

Peter Verhamme

×

245

Publications

30.4K

Citations

68

H-Index

YearCitations

Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease

John W. Eikelboom, Stuart J. Connolly, Jackie Bosch,

New England Journal of Medicine

2017

2.3K

The 2018 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation

Jan Steffel, Peter Verhamme, Tatjana Potpara,

European Heart Journal

2018

2.1K

Edoxaban for the Treatment of Cancer-Associated Venous Thromboembolism

Gary E. Raskob, Nick van Es, Peter Verhamme,

New England Journal of Medicine

2017

1.6K

Idarucizumab for Dabigatran Reversal

Charles V. Pollack, Paul A. Reilly, John W. Eikelboom,

New England Journal of Medicine

2015

1.4K

American Society of Hematology 2020 Guidelines for Management of Venous Thromboembolism: Treatment of Deep Vein Thrombosis and Pulmonary Embolism

Thomas L. Ortel, Ignacio Neumann, Walter Ageno,

Blood Advances

2020

1.3K

Idarucizumab for Dabigatran Reversal — Full Cohort Analysis

Charles V. Pollack, Paul Reilly, Joanne van Ryn,

New England Journal of Medicine

2017

1.1K

Updated European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist anticoagulants in patients with non-valvular atrial fibrillation

Hein Heidbüchel, Peter Verhamme, Marco Alings,

EP Europace

2015

1.1K

Full Study Report of Andexanet Alfa for Bleeding Associated with Factor Xa Inhibitors

Stuart J. Connolly, Mark Crowther, John W. Eikelboom,

New England Journal of Medicine

2019

920

Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease: an international, randomised, double-blind, placebo-controlled trial

Sonia S. Anand, Jackie Bosch, John W. Eikelboom,

The Lancet

2017

855

European Heart Rhythm Association Practical Guide on the use of new oral anticoagulants in patients with non-valvular atrial fibrillation

Hein Heidbüchel, Peter Verhamme, Marco Alings,

EP Europace

2013

790

Page 1